I-BEIJING SUCCEEDER TECHNOLOGY INC.

UXINGO LWENKONZO YOKUXINANA
ISICELO SEZIXAKI ZOKUHLAZIYA

Kwiintsomi zempilo zabantu, ijusi yelamuni idla ngokubizwa ngokuba "yi-natural blood thinner." Abantu abaninzi bakholelwa ukuba ukusela iglasi yamanzi elamuni yonke imihla kunokuthintela amahlwili egazi kwaye kuphucule ukujikeleza kwegazi. Nangona kunjalo, ngaba kukho nasiphi na isiseko sesayensi kwesi simangalo? Ngaba ijusi yelamuni ingayinciphisa ngokwenene igazi?

Ukuze siphendule lo mbuzo, kufuneka siqale sicacise inkcazo yesayensi yegama elithi "igazi elincinci".

Ngokwezonyango, izinto ezinciphisa igazi zahlulwe zibe ziindidi ezimbini: izinto ezithintela ukugabha kwegazi (ezifana ne-warfarin kunye ne-heparin), ezithintela umsebenzi wezinto ezibangela ukugabha kwegazi ukuthintela ukujiya kwegazi; kunye namayeza athintela ukugabha kwegazi (afana ne-aspirin), athintela ukugabha kwegazi ngokuthintela ukujiya kwegazi. La mayeza anefuthe elicacileyo lezonyango kwaye ziyindlela ebalulekileyo yokuthintela nokunyanga izifo zentliziyo kunye nemithambo yegazi.

Izinto eziphambili zejusi yelamuni ziquka ii-antioxidants ezifana ne-vitamin C, i-citric acid, kunye ne-flavonoids. I-Vitamin C ithatha inxaxheba kwiimpendulo ze-redox emzimbeni kwaye idlala indima ekugcineni ukuqina kweendonga zemithambo yegazi. Ii-Flavonoids zibonakalisiwe ukuba zinamandla okulwa nokuvuvukala kunye nokusebenza kwe-endothelial. Izifundo zezilwanyana zibonise ukuba ezinye izinto kwiziqhamo ze-citrus zinokuthintela kancinci ukuhlanganiswa kweeplatelet, kodwa amandla ale mpembelelo aphantsi kakhulu kunalawo asetyenziswa ngamayeza.

Uphononongo luka-2012 olwapapashwa kwi-American Journal of Clinical Nutrition luqaphele ukuba ukutya iziqhamo ze-citrus imihla ngemihla kunokunxulunyaniswa nomngcipheko ophantsi wokuqhekeka kwegazi, kodwa olu phando lubangelwe kakhulu kukuphucuka kokutya ngokubanzi kunesiphumo "sokuncitshiswa" sejusi yelamuni yodwa. Enyanisweni, isiphumo sokutya ekujiyeni kwegazi sibuthathaka kakhulu, asikwanelanga ukuphinda isiphumo sonyango samayeza.

Okubaluleke ngakumbi, ukulinganisa ijusi yelamuni kunye ne-blood thinner kunokubangela iingozi kwimpilo. Kwabo bathatha amayeza okunciphisa igazi, ukutya ijusi yelamuni ngokungaboniyo kunokunyusa umngcipheko wokopha ngenxa yempembelelo yokutya kunye namayeza. Abantu abasempilweni abaxhomekeke kwijusi yelamuni ukuthintela ukuqhekeka kwegazi ngelixa bengayinaki indlela yokutya elinganiselayo kunye nokuzilolonga banokulibazisa ulawulo lwempilo.

Ngokwembono, ijusi yelamuni, njengesiselo esinesondlo, ineengenelo ezithile zentliziyo xa isetyenziswa ngokulinganisela. Nangona kunjalo, indlela esebenza ngayo kukubonelela ngee-antioxidants kunye nokunyusa ukuthathwa kwamanzi, kwaye ayinxulumananga ngokuthe ngqo "nokunciphisa igazi."

Xa uthintela kwaye unyanga iimeko ezifana ne-thrombosis, kubalulekile ukulandela iingcebiso zonyango, ukusebenzisa amayeza ngokufanelekileyo, kunye nokugcina ukutya okunempilo kunye nendlela yokuphila enempilo—le yindlela yesayensi yokugcina impilo yemithambo yegazi.

КОНЦЕНТРАЦИЯ СЕРВИС КОАГУЛЯЦИЯ ДИАГНОСТИКА

АНАЛИЗАТОР РЕАГЕНТОВ ПРИМЕНЕНИЕ

I-Beijing Succeeder Technology Inc. (ikhowudi yesitokhwe: 688338) ibisoloko ibandakanyeka kakhulu kwicandelo lokuxilongwa kwe-coagulation ukususela ekusekweni kwayo ngo-2003, kwaye izimisele ukuba yinkokeli kweli candelo. Ikomkhulu layo liseBeijing, le nkampani ineqela elinamandla le-R&D, lemveliso kunye nelokuthengisa, eligxile ekuveliseni izinto ezintsha kunye nokusetyenziswa kwetekhnoloji yokuxilonga i-thrombosis kunye ne-hemostasis.

Ngenxa yamandla ayo abalaseleyo obuchwephesha, iSucceeder iphumelele iipatenti ezingama-45 ezigunyazisiweyo, kuquka iipatenti zokuyila ezili-14, iipatenti zemodeli yokusetyenziswa ezili-16 kunye neepatenti zoyilo ezili-15. Le nkampani ikwanazo nezatifikethi zobhaliso lwemveliso yezixhobo zonyango zeKlasi yesiBini ezingama-32, izatifikethi zokufaka iifayile zeKlasi yoku-1 ezi-3, kunye nesatifikethi se-EU CE kwiimveliso ezili-14, kwaye iphumelele isatifikethi senkqubo yolawulo lomgangatho se-ISO 13485 ukuqinisekisa ukugqwesa kunye nokuzinza komgangatho wemveliso.

I-Succeeder ayisiyo nje kuphela ishishini eliphambili leBeijing Biomedicine Industry Leapfrog Development Project (G20), kodwa ikwaphumelele kwiBhodi yoBuchule beSayensi neTekhnoloji ngo-2020, ifezekisa uphuhliso oluphezulu lwenkampani. Okwangoku, inkampani yakhe inethiwekhi yokuthengisa kuzwelonke egubungela amakhulu eearhente kunye neeofisi. Iimveliso zayo zithengiswa kakuhle kwiindawo ezininzi zelizwe. Ikwakhulisa ngokukhutheleyo iimarike zaphesheya kwaye iphucula rhoqo ukhuphiswano lwayo lwamazwe ngamazwe.